Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Jaguar Animal Health ( (JAGX) ) has provided an announcement.
On June 27, 2025, Jaguar Health, Inc. entered into exchange agreements with Iliad Research and Trading, L.P. and Streeterville Capital, LLC, issuing Series M Preferred Stock in exchange for reductions in outstanding royalty interests. This strategic move allows Jaguar Health to manage its financial obligations while offering stakeholders a structured investment opportunity through the Series M Preferred Stock, which includes specific rights and limitations, impacting the company’s capital structure and market positioning.
Spark’s Take on JAGX Stock
According to Spark, TipRanks’ AI Analyst, JAGX is a Neutral.
Jaguar Health’s stock score is primarily impacted by its poor financial performance, which poses significant risks. The company’s technical indicators and valuation metrics further highlight challenges. Although there are positive developments in clinical trials and corporate events, these are not sufficient to offset the financial and operational difficulties faced.
To see Spark’s full report on JAGX stock, click here.
More about Jaguar Animal Health
Average Trading Volume: 146,238
Technical Sentiment Signal: Sell
Current Market Cap: $3.31M
See more data about JAGX stock on TipRanks’ Stock Analysis page.